CYTOSORBENTS CORPORATION Debt Conversion, Converted Instrument, Amount
CYTOSORBENTS CORPORATION (CTSO) reported Debt Conversion, Converted Instrument, Amount of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2017-03-03
- CYTOSORBENTS CORPORATION debt conversion, converted instrument, amount for the quarter ending 2014-12-31 was $0.00.
- CYTOSORBENTS CORPORATION debt conversion, converted instrument, amount for the quarter ending 2014-09-30 was $804.60K.
- CYTOSORBENTS CORPORATION debt conversion, converted instrument, amount for the quarter ending 2013-12-31 was $0.00.
- CYTOSORBENTS CORPORATION debt conversion, converted instrument, amount for the quarter ending 2013-09-30 was $0.00, a 100.00% decline year-over-year.
- CYTOSORBENTS CORPORATION debt conversion, converted instrument, amount for fiscal 2016 was $0.00.
- CYTOSORBENTS CORPORATION debt conversion, converted instrument, amount for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- CYTOSORBENTS CORPORATION debt conversion, converted instrument, amount for fiscal 2014 was $1.99M, a 62.35% increase from fiscal 2013.
- CYTOSORBENTS CORPORATION debt conversion, converted instrument, amount for fiscal 2013 was $1.23M.
| Period end | Debt Conversion, Converted Instrument, Amount 0 month | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month | Debt Conversion, Converted Instrument, Amount 173 month | Debt Conversion, Converted Instrument, Amount 176 month | Debt Conversion, Converted Instrument, Amount 179 month | Debt Conversion, Converted Instrument, Amount 182 month | Debt Conversion, Converted Instrument, Amount 185 month | Debt Conversion, Converted Instrument, Amount 188 month | Debt Conversion, Converted Instrument, Amount 191 month | Debt Conversion, Converted Instrument, Amount 194 month | Debt Conversion, Converted Instrument, Amount 197 month | Debt Conversion, Converted Instrument, Amount 200 month | Debt Conversion, Converted Instrument, Amount 203 month | Debt Conversion, Converted Instrument, Amount 206 month | Debt Conversion, Converted Instrument, Amount 209 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-03 | |||||||||||||||||
| 2015-12-31 | $0.00 10-K · filed 2017-03-03 | |||||||||||||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $804.60K derived: sum of 2 quarters · filed 2017-03-03 | $1.99M 10-K · filed 2017-03-03 | |||||||||||||||
| 2014-09-30 | $804.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $1.99M 10-Q · filed 2015-11-13 | ||||||||||||||||
| 2014-06-30 | $1.19M 10-Q · filed 2015-08-13 | $14.36M 10-Q · filed 2014-08-12 | ||||||||||||||||
| 2014-03-31 | $13.18M 10-Q · filed 2014-05-14 | |||||||||||||||||
| 2014-03-07 | $10.20M 10-K · filed 2016-03-09 | |||||||||||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $0.00 derived: sum of 2 quarters · filed 2015-03-31 | $0.00 derived: sum of 3 quarters · filed 2015-03-31 | $1.23M 10-K · filed 2015-03-31 | $13.18M 10-K · filed 2014-03-31 | |||||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $0.00 derived: sum of 2 quarters · filed 2014-11-12 | $1.23M 10-Q · filed 2014-11-12 | $13.18M 10-Q · filed 2013-11-06 | ||||||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $1.23M 10-Q · filed 2014-08-12 | $13.18M 10-Q · filed 2013-08-14 | |||||||||||||||
| 2013-03-31 | $1.23M 10-Q · filed 2014-05-14 | $13.18M 10-Q · filed 2013-05-15 | ||||||||||||||||
| 2012-12-31 | $11.95M 10-K · filed 2013-04-03 | |||||||||||||||||
| 2012-09-30 | $290.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $290.05K derived: sum of 2 quarters · filed 2013-11-06 | $685.21K 10-Q · filed 2013-11-06 | $717.01K derived: sum of 4 quarters · filed 2013-11-06 | $12.63M 10-Q · filed 2012-11-21 | |||||||||||||
| 2012-06-30 | -$1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $395.15K 10-Q · filed 2013-08-14 | $426.95K derived: sum of 3 quarters · filed 2013-08-14 | $1.03M derived: sum of 4 quarters · filed 2013-08-14 | $12.34M 10-Q · filed 2012-08-13 | |||||||||||||
| 2012-03-31 | $395.15K 10-Q · filed 2013-05-15 | $426.95K derived: sum of 2 quarters · filed 2013-05-15 | $1.03M derived: sum of 3 quarters · filed 2013-05-15 | $1.22M derived: sum of 4 quarters · filed 2013-05-15 | $12.34M 10-Q · filed 2012-05-15 | |||||||||||||
| 2011-12-31 | $31.80K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-03 | $632.23K derived: sum of 2 quarters · filed 2013-04-03 | $823.29K derived: sum of 3 quarters · filed 2013-04-03 | $1.52M 10-K · filed 2013-04-03 | $11.95M 10-K · filed 2012-03-30 | |||||||||||||
| 2011-09-30 | $600.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-21 | $791.49K derived: sum of 2 quarters · filed 2012-11-21 | $1.48M 10-Q · filed 2012-11-21 | $11.92M 10-Q · filed 2011-11-14 | ||||||||||||||
| 2011-06-30 | $191.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | $882.90K 10-Q · filed 2012-08-13 | $11.32M 10-Q · filed 2011-08-15 | |||||||||||||||
| 2011-03-31 | $691.84K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |